Lansoprazole
Product Images NDC 50090-2225

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 50090-2225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lansoprazole 01)

FDA Label Image

Figure 1 (Lansoprazole 02)

Figure 1 (Lansoprazole 02)
This appears to be a chart or table showing the mean severity of day heartburn for patients in a study, with scores ranging from none to severe. The chart compares the results for a placebo group with two treatment groups receiving different doses of lansoprazole.*
FDA Label Image

Figure 2 (Lansoprazole 03)

Figure 2 (Lansoprazole 03)
Mean severity of night heartburn by study day for evaluable patients is being reported for different medication groups including placebo, 15mg daily Lansoprazole and 30mg daily Lansoprazole. Unfortunately, the limited text does not provide any specific value or insight into the study's findings.*
FDA Label Image

Label Image (Lbl500902225)

Label Image (Lbl500902225)
LANSOPRAZOLE is a medication that comes in a pack of 30 delayed release capsules. The recommended storage temperature for the capsules is 7 degrees Celsius. The rest of the text is not readable and appears to be gibberish.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.